A Mixture of Essential Oils from Three Cretan Aromatic Plants Inhibits SARS-CoV-2 Proliferation: A Proof-of-Concept Intervention Study in Ambulatory Patients
Authors:
- Christos LionisChristos Lionis
- Elena PetelosElena Petelos
- Manolis LinardakisManolis Linardakis
- Athanasios DiamantakisADAthanasios Diamantakis
- Emmanouil SymvoulakisEmmanouil Symvoulakis
- Maria-Nefeli KarkanaMKMaria-Nefeli Karkana
- Marilena KampaMarilena Kampa
- Stergios A. PirintsosSPStergios A. Pirintsos
- George SourvinosGSGeorge Sourvinos
- Elias CastanasECElias Castanas
Open Access
Abstract
Introduction: The need for effective therapeutic regimens for non-critically ill patients during the COVID-19 pandemic remained largely unmet. Previous work has shown that a combination of three aromatic plants’ essential oils (CAPeo) (Thymbra capitata (L.) Cav., Origanum dictamnus L., Salvia fruticose Mill.) has remarkable in vitro antiviral activity. Given its properties, it was urgent to explore its potential in treating mild COVID-19 patients in primary care settings. Methods: A total of 69 adult patients were included in a clinical proof-of-concept (PoC) intervention study. Family physicians implemented the observational study in two arms (intervention group and control group) during three study periods (IG2020, n=13, IG2021/22, n=25, and CG2021/22, n=31). The SARS-CoV-2 infection was confirmed by real-time PCR. The CAPeo mixture was administered daily for 14 days per os in the intervention group, while the control group received usual care. Results: The PoC study found that the number and frequency of general symptoms, including general fatigue, weakness, fever, and myalgia, decreased following CAPeo administration. By Day 7, the average presence (number) of symptoms decreased in comparison with Day 1 in IG (4.7 to 1.4) as well as in CG (4.0 to 3.1), representing a significant decrease in the cumulative presence in IC (−3.3 vs. −0.9, p < 0.001; η2 = 0.20) on Day 7 and on Day 14 (−4.2 vs. −2.9, p = 0.027; η2 = 0.08). Discussion/Conclusions: Our findings suggest that CAPeo possesses potent antiviral activity against SARS-CoV-2 in addition tο its effect against influenza A and B and human rhinovirus HRV14 strains. The early and effective impact on alleviating key symptoms of COVID-19 may suggest this mixture can act as a complementary natural agent for patients with mild COVID-19.Keywords
All Related Versions
Funding Information
- Clinic of Social and Family Medicine at the University of Crete
- Olvos Science SA
This publication has 36 references indexed in Scilit:
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktailScience, 2020
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019Journal of Internal Medicine, 2020
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and ApplicationAnnals of Internal Medicine, 2020
- From wild harvest towards precision agriculture: Use of Ecological Niche Modelling to direct potential cultivation of wild medicinal plants in CreteScience of The Total Environment, 2019
- Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tractJournal of Herbal Medicine, 2019
- Post-market outcome of an extract of traditional Cretan herbs on upper respiratory tract infections: a pragmatic, prospective observational studyBMC Complementary and Alternative Medicine, 2017
- Reporting effectiveness of an extract of three traditional Cretan herbs on upper respiratory tract infection: Results from a double-blind randomized controlled trialJournal of Ethnopharmacology, 2015
- Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studiesThe American Journal of Clinical Nutrition, 2005
- Absorption and metabolism of polyphenols in the gut and impact on healthBiomedicine & Pharmacotherapy, 2002